Quantcast

Latest Memorial Sloan–Kettering Cancer Center Stories

2014-02-28 12:28:07

The New York Genome Center and The Rockefeller University's finding of a mutation that is present in 15 out of 15 patients suggests new opportunities for diagnosis and treatment of cancer, and leads to a high profile Science publication NEW YORK, Feb. 28, 2014 /PRNewswire-USNewswire/ -- A father-daughter scientific collaboration that began after the daughter was diagnosed with a rare liver cancer has led to an important finding and could have broader implications for many other rare...

2014-02-25 08:28:01

NEW YORK, Feb. 25, 2014 /PRNewswire/ -- Memorial Sloan Kettering announced the appointment of Pereira & O'Dell in New York as its creative agency of record and Media Storm as its media agency of record following competitive reviews that concluded earlier this month. "For 130 years, Memorial Sloan Kettering has focused relentlessly on a singular mission: discovering better treatments for cancer and improving the lives of those who are touched by cancer. Pereira & O'Dell and...

2014-02-19 23:31:12

Colleen’s Dream Foundation has granted $11,000 to Memorial Sloan-Kettering Cancer Center to help fund ovarian cancer research being conducted by Dr. Vance Broach, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) February 19, 2014 With the help of ovarian cancer survivor Jill Pall and NFL kicker Ryan Quigley, Colleen’s Dream Foundation has granted $11,000, to Memorial Sloan-Kettering Cancer Center to help fund ovarian cancer research being...

2014-02-10 23:01:27

Lally was a fundraiser at University of Michigan Health System, Dartmouth-Hitchcock Medical Center and Memorial Sloan Kettering GREAT NECK, NY (PRWEB) February 10, 2014 The North Shore-LIJ Health System today announced the appointment of Brian Lally as senior vice president and chief development officer. In leading the North Shore-LIJ Foundation, Mr. Lally will work to cultivate private charitable support for the health system’s programs, endowment and facilities. He will be...

2014-01-31 12:25:20

U.S. Sen. Charles E. Schumer Helps Commemorate Opening of Building that Nearly Doubles Medical College's Research Space, Enhances Student Education NEW YORK, Jan. 31, 2014 /PRNewswire/ -- Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill...

2014-01-13 16:25:48

Juno CEO Hans Bishop to Address JP Morgan's 32nd Annual Healthcare Conference SEATTLE, Jan. 13, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today an expanded Series A including Bezos Expeditions, the personal investment company of Jeff Bezos, and leading venture capital firm Venrock. The total Series A will exceed $145M. (Logo:...

2014-01-06 08:25:22

NEW YORK, Jan. 6, 2014 /PRNewswire/ -- Cancer research in the U.S. got a critical boost today as the six Ludwig Centers at Johns Hopkins University, Harvard University, the Massachusetts Institute of Technology, Memorial Sloan-Kettering Cancer Center, Stanford University and the University of Chicago received a total of $540 million as part of a gift from Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig. This new funding ranks among the largest private philanthropic...

2013-12-16 18:14:37

Rates of programmed cell death higher in mice treated with experimental drug than in untreated animals with same cancer An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. The...

2013-12-03 23:20:05

Scientific investigators at five institutions receive $1 million to spur better outcomes for patients with acral melanoma and provide breakthroughs through the use of genome sequencing. Washington, DC (PRWEB) December 03, 2013 The Melanoma Research Alliance (MRA), the leading private funder of melanoma research, and the Hidary Foundation, the philanthropic arm of technology entrepreneur Jack Hidary and his family, today announced a new research program with researchers at five...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related